AVAH vs. HCAT

In the year-to-date period, AVAH achieves a -7.66% return, which is significantly higher than HCAT's -49.36% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AVAH Sharpe Ratio is 1.05, which is higher than the HCAT Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of AVAH and HCAT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AVAH nor HCAT has paid dividends to shareholders.

The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum HCAT drawdown of -93.89%. Use the drawdown chart below to compare losses from any high point for AVAH and HCAT. For additional features, visit the drawdowns tool.

Aveanna Healthcare Holdings Inc. (AVAH) and Health Catalyst, Inc. (HCAT) have volatilities of 16.32% and 15.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Health Catalyst, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.